AR-V7 – a novel predictive and prognostic biomarker: Individualized therapy for castration-resistant prostate cancer [AR-V7 – ein neuer prädiktiver und prognostischer Biomarker: Therapieindividualisierung beim kastrationsresistenten Prostatakarzinom]

被引：0
|
作者：
Oing C. [1 ]
von Amsberg G. [1 ]
Bokemeyer C. [1 ]
机构：
[1] II. Medizinische Klinik – Onkologie, Hämatologie und Stammzelltransplantation mit Sektion Pneumologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg
来源：
Der Onkologe | 2015年 / 21卷 / 9期
关键词：
D O I：
10.1007/s00761-015-3019-9
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：846 / 847
页数：1
相关论文
共 50 条
  • [31] CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression
    Deng, Chuangzhong
    Chen, Jieping
    Guo, Shengjie
    Wang, Yanjun
    Zhou, Qianghua
    Li, Zaishang
    Yang, Xingping
    Yu, Xingsu
    Zhang, Zhenfeng
    Zhou, Fangjian
    Han, Hui
    Yao, Kai
    WORLD JOURNAL OF UROLOGY, 2017, 35 (08) : 1213 - 1221
  • [32] Clinical Validation of AR-V7 Detection in Circulating Tumor Cells from Castration-Resistant Prostate Cancer Patients
    Lokhandwala, Parvez M.
    Riel, Stacy
    Gocke, Christopher D.
    Lin, Ming-Tseh
    Zheng, Gang
    Antonarakis, Emmanuel S.
    Luo, Jun
    Eshleman, James R.
    MODERN PATHOLOGY, 2016, 29 : 247A - 247A
  • [33] CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression
    Chuangzhong Deng
    Jieping Chen
    Shengjie Guo
    Yanjun Wang
    Qianghua Zhou
    Zaishang Li
    Xingping Yang
    Xingsu Yu
    Zhenfeng Zhang
    Fangjian Zhou
    Hui Han
    Kai Yao
    World Journal of Urology, 2017, 35 : 1213 - 1221
  • [34] The MNK inhibitor EB1 sensitizes AR-V7 positive castration-resistant prostate cancer to enzalutamidee
    Garcia-Ortega, Sara
    Suarez-Cabrera, Leticia
    Morote, Joan
    Mendez, Olga
    Cano-Galietero, Marta
    Muro-Blanc, Elena
    Borrell, Jose I.
    Santamaria, Anna
    Ramon y Cajal, Santiago
    Hummer, Stefan
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Detection of AR-V7 mRNA in whole blood may not predict the effectiveness of novel endocrine drugs for castration-resistant prostate cancer
    Takeuchi, Takumi
    Okuno, Yumiko
    Hattori-Kato, Mami
    Zaitsu, Masayoshi
    Mikami, Koji
    RESEARCH AND REPORTS IN UROLOGY, 2016, 8 : 21 - 25
  • [36] CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients
    Isebia, Khrystany T.
    Mostert, Bianca
    Belderbos, Bodine P. S.
    Buck, Stefan A. J.
    Helmijr, Jean C. A.
    Kraan, Jaco
    Beaufort, Corine M.
    Van, Mai N.
    Oomen-de Hoop, Esther
    Sieuwerts, Anieta M.
    IJcken, Wilfred F. J. van
    van Vroonhoven, Mirjam C. G. N. van den Hout
    Brouwer, Rutger W. W.
    Oole, Edwin
    Hamberg, Paul
    Haberkorn, Brigitte C. M.
    Helgason, Helgi H.
    de Wit, Ronald
    Sleijfer, Stefan
    Mathijssen, Ron H. J.
    Martens, John W. M.
    Jansen, Maurice P. H. M.
    van Riet, Job
    Lolkema, Martijn P.
    EUROPEAN JOURNAL OF CANCER, 2022, 177 : 33 - 44
  • [37] Study on Pradiction of AR-V7 and CTC Circulation in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Rexer, H.
    Hammerer, P.
    Schostak, M.
    Koenig, F.
    AKTUELLE UROLOGIE, 2018, 49 (05) : 392 - 393
  • [38] Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13 Editorial Comment
    Atala, Anthony
    JOURNAL OF UROLOGY, 2019, 201 (01): : 33 - 34
  • [39] DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7
    Moon, Sue Jin
    Jeong, Byong Chang
    Kim, Hwa Jin
    Lim, Joung Eun
    Kwon, Ghee Young
    Kim, Jeong Hoon
    ONCOGENE, 2018, 37 (10) : 1326 - 1339
  • [40] AR-V7 expression facilitates accelerated G2/M phase transition in castration-resistant prostate cancer
    Saini, Taruna
    Gupta, Parth
    Raut, Rajnikant
    Nayak, Vinayak
    Bharathnaveen, Pabbithi
    Mishra, Parul
    Misra, Ashish
    EXPERIMENTAL CELL RESEARCH, 2024, 438 (01)
12345